Collecting and analyzing patient samples to improve treatments for blood cancers
Official title: Pathology Core
Funded at Coriell Institute for Medical Research · NIH-10886778 · Data updated 2026-11-12
This study is looking for patients with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) to share blood and bone marrow samples during their treatment, so researchers can learn more about how to make treatments better and help patients feel better in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Coriell Institute for Medical Research NIH-funded |
| Lab location | 1 site (Camden, United States) |
| Project start | August 16, 2021 |
| Project end | June 30, 2026 |
| Funding year | 2024 |
| Award (this year) | $221,991 |
| NIH project number | 5P50CA254897-04 |
| Project ID | NIH-10886778 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals diagnosed with relapsed or refractory AML or MDS who are undergoing treatment.
✕Less likely to help
Patients who are not diagnosed with blood cancers or those who are not currently undergoing treatment may not benefit from this research.
What this research studies
This research focuses on the collection and analysis of patient-derived biospecimens, such as blood and bone marrow samples, to better understand and improve treatments for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Patients will provide samples at various stages of their treatment, which will be processed and analyzed to assess the effectiveness of different therapeutic approaches. The research aims to identify biological markers and mechanisms that can inform future treatment strategies and improve patient outcomes.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for patients with blood cancers, potentially improving survival rates and quality of life.
How similar studies have gone: Previous research has shown success in using patient-derived biospecimens to enhance understanding of cancer treatments, indicating that this approach is promising.
Where this research is happening
-
Coriell Institute for Medical Research
Camden, United States Active
Researchers
- Principal investigator: Williams, Bart O — Coriell Institute for Medical Research
- Study coordinator: Williams, Bart O
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.